Stay updated on B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page.

Latest updates to the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. The previous revision was removed.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange Detected- Page revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision: v3.4.2 replaces the previous Revision: v3.4.1 on the page. This update appears to be a site version change with no evident impact on the study details or user actions.SummaryDifference0.0%

- Check55 days agoChange DetectedAdded Revision: v3.4.1 to the page header. Removed the lapse-in-funding notice and the previous Revision: v3.4.0 reference.SummaryDifference0.3%

- Check62 days agoChange DetectedNew notice banner informs users of a lapse in government funding and potential downtime. It states that the NIH Clinical Center is open and provides links to cc.nih.gov and opm.gov for current operating status.SummaryDifference0.2%

- Check69 days agoChange DetectedAdded a glossary display, updated the QC label to 'Last Update Submitted that Met QC Criteria', standardized capitalization for 'No FEAR Act Data', and bumped the site revision to v3.4.0 (from v3.3.4).SummaryDifference0.1%

Stay in the know with updates to B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page.